Telesis Bio Quote - TBIO

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.56

Bid

3.55

Offer

3.95

Volume

301

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

6.142M

Previous Close

3.65

Open

Last Trade

100

3.56

(formt)

Last Trade Time

22:04:31

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

1,682,794

Dividend Yield

PE Ratio

-0.13

Earnings Per Share (EPS)

-29.13

Revenue

27.51M

Net Profit

-49.02M

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.codexdna.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Telesis Bio Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TBIO. The last closing price for Telesis Bio was US$3.65. Over the last year, Telesis Bio shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Telesis Bio currently has 1,682,794 shares in issue. The market capitalisation of Telesis Bio is US$6.14 million. Telesis Bio has a price to earnings ratio (PE ratio) of -0.13.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
I88Infini Resources Ltd	AUD 0.35 (125.81%)	6.1M
WLDWellard Limited	AUD 0.037 (117.65%)	2.43M
TMGODTrigg Minerals Ltd	AUD 0.002 (100.00%)	1.19M
BASOBass Oil Limited	AUD 0.002 (100.00%)	661.73k
BRXOABelararox Ltd	AUD 0.025 (92.31%)	122.45k
LBTOALBT Innovations	AUD 0.004 (-63.64%)	70.89M
OSXOOsteopore Limited	AUD 0.002 (-60.00%)	356.09k
SPQOBSuperior Resources Ltd	AUD 0.001 (-50.00%)	500k
TD1Tali Digital Limited	AUD 0.001 (-33.33%)	310k
MTBMount Burgess Mining Nl	AUD 0.001 (-33.33%)	28.57k
LBTOALBT Innovations	AUD 0.004 (-63.64%)	70.89M
MMIMetro Mining Ltd	AUD 0.054 (14.89%)	42.27M
ACWActinogen Medical Limited	AUD 0.065 (4.84%)	37.36M
88E88 Energy Limited	AUD 0.0025 (0.00%)	33.41M
STXStrike Energy Limited	AUD 0.23 (-16.36%)	28.74M